ReviewNature reviews. Clinical oncology2024

Navigating the changing landscape of BTK-targeted therapies for B cell lymphomas and chronic lymphocytic leukaemia.

Michele D Stanchina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.